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Abstract: The exact causes of failure of anterior cruciate ligament (ACL) reconstruction are still
unknown. A key to successful ACL reconstruction is the prevention of bone tunnel enlargement
(BTE). In this study, a new strategy to improve the outcome of ACL reconstruction was analyzed
using a bioresorbable polylactide (PLA) stent as a catalyst for the healing process. The study included
24 sheep with 12 months of age. The animals were randomized to the PLA group (n = 16) and
control group (n = 8), subjected to the ACL reconstruction with and without the implantation of
the PLA tube, respectively. The sheep were sacrificed 6 or 12 weeks post-procedure, and their knee
joints were evaluated by X-ray microcomputed tomography with a 50 µm resolution. While the
analysis of tibial and femoral tunnel diameters and volumes demonstrated the presence of BTE in both
groups, the enlargement was less evident in the PLA group. Also, the microstructural parameters
of the bone adjacent to the tunnels tended to be better in the PLA group. This suggested that the
implantation of a bioresorbable PLA tube might facilitate osteointegration of the tendon graft after
the ACL reconstruction. The beneficial effects of the stent were likely associated with osteogenic and
osteoconductive properties of polylactide.
Keywords: anterior cruciate ligament reconstruction; bone tunnel enlargement; X-ray microtomography;
polylactide
1. Introduction
The causes of failure of anterior cruciate ligament (ACL) reconstruction are still a matter of debate.
While many various ACL reconstruction techniques have been proposed thus far, none of them seems
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to be optimal and complication-free [1–3]. The failures of ACL reconstruction might be associated with
an inappropriate orientation of bone tunnels, use of improper fixation methods and materials, and
inadequate rehabilitation, as well as with mechanical behavior of the bone and biological processes
that occur during remodeling, maturation, and incorporation of the graft [4,5]. The healing potential
of a newly implanted graft is relatively low [6–8] and is primarily determined by conditions within
proximity of the bone tunnel and soft tissue of the graft, including the intra-articular environment.
Osteointegration of the tendon grafts used for ACL reconstruction is still far from satisfactory, although
several strategies have been postulated to improve the process [9–19].
Another critical determinant of successful ACL reconstruction is the prevention of bone tunnel
enlargement (BTE), a phenomenon of mechanical and biological etiology. The mechanical causes of
BTE might be related to the tunnel drilling technique, graft fixation technique, vibrations at the tunnel
entry, and movements of the graft referred to as “bungee effect” and “windshield wiper effect” [20–25].
The biological mechanisms involved in the BTE include accumulation of intra-articular fluid, which
penetrates to the space between the graft and the wall of the bone tunnel. The sites in which the
graft is not adjacent closely to the bone tunnel wall, the so-called “dead space”, are particularly prone
to fluid accumulation. The intra-articular fluid that accumulates after the ACL rupture contains
proinflammatory cytokines, which are responsible for local osteolysis [26–29]. Another biological
mechanism implicated in BTE pathogenesis might be the so-called “synovial bathing effect”; due to its
excessive accumulation after ACL reconstruction, synovial fluid might be pressed into the bone tunnel
and cause enlargement thereof [23,30,31].
Polylactide (PLA) is a polymer used in surgical practice for bone anastomosis implants (screws,
plates, rods). PLA owes its popularity not only to its good biocompatibility (the best among polymers)
but also to the ease of implant formation (injection, extrusion, printing). Polylactide is a biodegradable
polymer, the durability of which can be determined in vivo by in vitro degradation tests. Degradation
of polylactide was a subject of many published studies [32–34]. According to some authors, the
degradation of PLA in strongly hydrated environments occurs through the penetration of water
molecules and hydrolysis of ester bonds, which results in an increase in the concentration of terminal
carboxylic groups [35]. Other researchers have suggested that the PLA polymer chain is autocatalyzed
due to acidification of the environment (dissociation effect of carboxyl groups) [36]. The result of
material degradation is a decrease in molecular weight and a larger dispersion of average molecular
weight. The kinetics of the process depends on the structure of the polymer chain, especially the
presence of L or D enantiomer and their ratio [34]. Many methods can be used to control the
degradation process in order to reduce the negative effect of PLA autocatalysis. One of them is the
addition of modifiers capable of connecting hydronium ions to the polymeric matrix [37], as it is the
case with PLA-based nanocomposites modified with ceramic particles. Unfortunately, in the case
of new materials, many other parameters need to be tested, and validated in vitro and in vivo tests
are required. Therefore, it seems easier to use a minimum amount of pure PLA, e.g., in the form of
membranes or highly porous materials, especially when their task is not limited to the transfer of
stress. An example of such a solution is presented below. The perforated microscopic material also
has pores at the microstructural level, thus reducing the total amount of material used to produce
the implant. The presented solutions significantly affect the durability of the material in vitro, which
allows approximating the time of degradation in vivo.
In our present study, we analyzed another strategy to improve the outcome of ACL reconstruction,
using a bioresorbable polylactide (PLA) stent as a catalyst for the healing process. The stent was
produced from poly(L/DL-lactide) 80/20 (80:20 PL/DLA is name of molar ratio the combination of
L-lactate (80%) and DL-lactate (20%)) [38–42]. Bioresorbable PLA polymers, in the form of powder,
beads, or paste, have already been tested in sheep [39,41], rabbits [42,43], and humans [41,43]. However,
applied in a non-solid form, PLA did not provide sufficient mechanical support, which eventually
contributed to BTE. Thus, in this study, we verified whether PLA in another form, a tube-shaped
perforated stent with a porosity of 45%, improved graft-bone integration after ACL reconstruction.
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We hypothesized that implantation of the stent could accelerate the bone healing process and prevent
the accumulation of non-uniform forces inside the bone tunnel, reducing the risk of BTE. This hypothesis
was first verified in a virtual environment, based on finite element analysis of the stress-strain response
from the bone, graft, and PLA stent (see: Appendix A, Figures A2–A5). The results constituted the basis
for the proper animal experiment, the results of which are described below. The microarchitecture of
bone tunnels and adjacent bone was analyzed based on high-resolution, high-quality images obtained
during X-ray microtomography (micro-CT). The study involved sheep, as this animal was previously
shown to be a good model for orthopedic research [44,45].
2. Materials and Methods
2.1. Animals and Specimen Preparation
The study included 24 male sheep with 12 months of age and body weights ranging between 35
and 40 kg. The protocol of the study was approved by the Animal Ethics Committee at the Institute
of Pharmacology, Polish Academy of Sciences in Krakow (decisions no. 820/2011 and 836/2011 of 27
January 2011 and 19 May 2011, respectively). The animals were randomized into two groups: the
PLA group (n = 16) and the control group (n = 8). The sheep were kept under standard husbandry
conditions (stalls with straw bedding, temperature 10–25 ◦C, natural light/dark cycle according to the
season, with 8 to 16 h lights on), two animals per stall, matched according to the experimental group.
The animals were fed with hay (ad libitum) and pasture (0.3 kg/animal/day) and had unlimited access
to water. The food was restricted one day before the ACL reconstruction procedure.
The reconstruction procedure was carried out under general anesthesia by inhalation nitrous oxide
25–40% (Linde Gas, Krakow, Poland), isoflurane 0.6–3% (Aerrane 250 mL, Baxter, Warsaw, Poland),
and oxygen 30–40% (Medical Oxygen, Linde Gas, Warsaw, Poland). First, the animal’s ACL was cut
and removed from the joint. Then, tibial and femoral bone tunnels, 4.5 mm in diameter, were drilled
using the ACL insertions as the landmarks (Figure 1). The tunnels were drilled in the medial aspect of
the proximal tibial metaphysis and distal femoral metaphysis lateral to the condyles. The autograft
was harvested from the Achilles tendon. In the control group, the autograft, 4.5 mm in diameter, was
pulled through both bone tunnels, and then, its ends were fixed extracortically to the femur and tibia
with an EndoButton and button (Figure 1). In the PLA group, PLA tubes (3.5 mm in diameter) were
first placed in the tunnels, and then, the autograft, also 3.5 mm in diameter, was inserted into the tubes,
so it adhered tightly to their inner walls. Finally, the graft’s ends were fixed analogically, as in the
control group.
After the procedure, the sheep were placed in stalls and allowed to move freely. The animals were
controlled on a daily basis for 6–12 weeks. Twelve sheep, four from the control group and eight from
the PLA group, were sacrificed at 6 weeks post-reconstruction, followed by another 12 sheep, four from
the control group and eight from the PLA group, at 12 weeks after the procedure. The animals were
euthanized with pentobarbital sodium (Morbital, Biovet, Pulawy, Poland) overdose (50–80 mg/kg), and
the previously operated knee joints were dissected to enable accurate examination of the bone tunnels.
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Figure 1. Scheme of the ACL reconstruction, type of graft fi , and the implantation of polylactide
(PLA) perforated tube.
2.2. Polylactid Tubes
The PLA stents were produced from bioresorbable poly(L/DL-lactide) 80/20 (PURAC Biochem,
Gorinchem, The Netherlands). The tubes were prepared using a thermal method. Briefly, the polymer
pellets were heated to 156 ◦C, which is close to the melting point for PLA, and shaped by compression
in a cylindrical metallic form to obtain a polymer film with approximately 500 µm thickness. Each PLA
tube, 3.5 mm in diameter and 25 mm in length, had twenty circular-shaped perforations (0.5 mm
in diameter) per square cm (Figure 2). The perforations were made with a laser device. Upon
manufacturing, the PLA tubes underwent low-temperature plasma sterilization (H2O2, 40 ◦C).Polymers 2019, 11, x FOR PEER REVIEW 5 of 21 
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Figure 2. PLA perforated tube.
Detailed methodology of polymer membrane production and the results of functional testing can
be found elsewhere [46,47]. Briefly, polymer membranes were produced from a synthetic PL/DLA
polymer, using a phase inversion meth d. The flat membrane used later for the production of the
stent was manufactured by casting. A combination of tetrahydrofuran and cetone in a 10:1 r tio was
used as a solv nt. The polymer was homogenized for 3 h to btain a homogeneous solution (3% w/v).
Then, a porogenic gent, dimethylsulfoxide (DMSO), and pure water (UHQ) were added in a 1:1 ratio.
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The suspension was homogenized for a few minutes, poured onto Petri plates, dried, and conditioned.
Then, the membranes obtained, as described above, were bathed in ethyl alcohol to remove the remains
of DMSO. The final porosity of the membrane was 45%. The pore distribution in the membrane was
binomodal, proving the existence of two-pore populations: the first one, more numerous with the size
of about 26 µm (85%), and the second one with the average size of about 7 µm (10%). These values
were determined on the basis of microscopic image analysis obtained with a scanning electron
microscope (Nova NanoSEM, FEI, Hillsboro, OR, USA)) (Figure 3). The physicochemical properties
of the membranes were determined based on their roughness and wettability tests. The influence of
the in vitro environment on the durability of the membrane’s material was monitored based on pH
alterations in water and phosphate-buffered saline extracts. In line with the standard requirements for
degradability testing, the membranes were kept in an incubator for 4 weeks. The molecular weight
of the membrane at the end of the experiment was determined with an Ubbelohde viscometer, with
norm DIN 51562, SI Analytics, Germany (measuring liquid tethrahydrofurane, K = 4.85 × 10−4 dL/g
and a = 0.68). The degradability of the membrane was also monitored in vitro (three months/H2O/
37 ◦C/5% CO2 incubation); over the three-month monitoring period, the mean molecular weight of the
membrane determined with an Ubbelohde viscometer decreased from 200 to 145 kDa. The pH of the
immersion medium decreased slightly during the monitoring period, down to 6.2.Polymers 2019, 11, x FOR PEER REVIEW 6 of 21 
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2.3. Micro-CT Scanning
The knee joints from 24 sheep were scanned at the X-ray Microtomography Lab (XML), Institute
of Computer Science, University of Silesia (Sosnowiec, Poland), using an XMT scanner (v|tome|x s, GE
Sensing and Inspection Technologies, Phoenix|x-ray, Wunstorf, Germany). The X-ray images were
acquired using a 140 kV voltage, 350 mA current, and 50 µm resolution. To accurately analyze the
regeneration of the tibial and femoral tunnels on micro-CT, the images underwent reslicing so that the
long central axis of each image corresponded to the exact center of the bone tunnel. An example of
reslicing and image transformation, with axial cross-sections perpendicular to the bone tunnel’s axis
of symmetry, is shown in Figure 4. All advanced image analyses were carried out with ImageJ, an
open-source image enumeration software package (US National Institute of Health, Bethesda, MD,
USA) [48].
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The analysis began with the selection of the tunnel’s edge on each axial cross-section of the tibia
and femur (Figure 5). The boundary between the intra-tunnel space and the bone was chosen manually,
to obtain an optimal area in the variable portion of the bone tunnel. To avoid a time-consuming
selection of edges on each slice, the operator marked the edges on several slices, and then, the regions
of interest (ROIs) were interpolated onto the remaining slices.
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2.4. Analysis of the Tunnel Diameter After the ACL Reconstruction
The diameter of the bone tunnel in the axial cross-section (Figure 5) was estimated by computing
the diameter of the circle fitted automatically into the selected ROI of each slice, using ImageJ 1.49b
software (Wayne Rasband National Institutes of Health, Bethesda, MD, USA) [48]. Then, mean
diameters were calculated for three segments of the tunnel: entry, midportion, and exit (Figure 6) using
pre-specified ROIs. The three segments of the tunnel were defined by dividing its entire length into
three equal parts.Polymers 2019, 11, x FOR PEER REVIEW 8 of 21 
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2.5. Measurement of Tunnel Volume and Determination of Histomorphometric Parameters
To examine the entry of bone tunnel in more detail, its volume and histomorphometric parameters
of the adjacent bone were determined. The measurements were taken inside the tunnel, 5 mm from
its entry. Tunnel volume was calculated using the previously defined ROIs. Histomorphometric
parameters of the adjacent bone, such as bone volume fraction (BV/TV), trabecular thickness (Tb.Th),
and connectivity density (Conn.D), were determined based on micro-CT i ages. To obtain the
measure ents of trabecular structures, the area inside each ROI (Figure 5) was increased three times
(Figure 7a,b). Th maximum entropy method, an automated global thresholding method, w s prop sed
for the segmentation of bone samples in our s udy; in this meth d, the threshold was chosen based on
maxi izing the inte -class entropy. Then, differe t auto ated algor thms were tested to select the most
appropriate method for the s gm ntation of trabecular bone in sheep. Bone volume fraction (BV/TV),
calculated as bone volum divided by total volume, corresponds to the percentage of mineralized b ne
located within the volume of interest (VOI). Trabecular thickness (Tb.Th) provides infor ation about
the thickness of trabecular structures. Connectivity is defined as the maximum number of trabecular
connections that can be severed before the structure is split into two separate parts [49]. All three
parameters were calculated using the BoneJ plugin [50] within the ImageJ software.
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2.6. Three-Dimensional Visualization
The changes in histomorphometric parameters of adjacent bone were visualized using Drishti
open-source software [51]. On three-dimensional images (Figure 8), the bone tunnels were presented
in sagittal cross-section, with the extracortical button placed at the bottom left side of the image.
2.7. Statistical Analysis
Normal distribution of the study variables was verified with the Shapiro–Wilk test, and the
equality of their variances was checked with Levene’s test. The significance of intergroup differences
was verified with non-parametric Mann–Whitney U-test. All calculations were carried out with
Statistica 10 (StatSoft, Tulsa, OK, USA), with the threshold of statistical significance set at p < 0.05.
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3. Results
3.1. Bone Tunnel Measurements
Diameters of the bone tunnels after various healing time (6 and 12 weeks) are presented in
Figure 8 and Table 1. At 6 weeks, the diameters of the tunnels in all segments except the midportion
and exit of the femoral tunnel turned out to be significantly smaller in the PLA group than in the
controls. At 12 weeks, the statistically significant between-group differences were observed solely
for the midportion and exit of the tibial tunnel. While the diameters of most segments at 6 and 12
weeks did not differ significantly in the control group, a significant increase in all three diameters of
the femoral tunnel was observed in the PLA group (Figure 9).
Table 1. Morphometric parameters of tibial and femoral tunnels at 6 and 12 weeks post-ACL (anterior
cruciate ligament).
Variable
Tibia Femur
6 Weeks 12 Weeks p-Value 6 Weeks 12 Weeks p-Value
Tunnel Entry Diameter
Controls 8.1 ± 1.3 7.7 ± 1.2 0.665006 8.3 ± 0.9 8.8 ± 1.5 0.665006
PLA group 5.7 ± 0.6 6.8 ± 1.3 0.156255 6.1 ± 0.9 7.6 ± 1.1 0.017673
p-value 0.008475 0.350238 0.008475 0.298618
Tunnel Midportion Diameter
Controls 8.1 ± 1.8 8.5 ± 1.5 0.885234 6.2 ± 1.2 8.0 ± 1.4 0.193932
PLA group 5.7 ± 0.7 6.3 ± 1.0 0.270149 5.8 ± 0.5 7.1 ± 0.4 0.003167
p-value 0.021857 0.021857 0.552215 0.219304
Tunnel Exit Diameter
Controls 7.4 ± 1.4 9.2 ± 2.0 0.193932 4.4 ± 0.3 6.3 ± 1.7 0.112352
PLA group 5.1 ± 0.8 5.8 ± 0.8 0.103563 5.6 ± 0.5 6.4 ± 0.5 0.032278
p-value 0.008475 0.033753 0.008475 0.924719
Tunnel Volume
Controls 277.6 ± 80.3 235.5 ± 75.0 0.470487 257.2 ± 95.5 311.5 ± 104.2 0.470487
PLA group 133.9 ± 31.1 200.4 ± 75.6 0.083124 142.6 ± 44.4 213.8 ± 53.9 0.033161
p-value 0.008475 0.444697 0.033753 0.240956
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The results for the tunnel volume were consistent with those for the tunnel diameters (Figure 10,
Table 1). In both tibia and femur, mean tunnel volumes at 6 weeks, but not at 12 weeks, were
significantly smaller in the PLA group than in the controls. In line with those findings, a significant
increase in the femoral tunnel volume and a tendency to increase in the tibial tunnel volume were
observed at 12 weeks in the PLA group but not in the control group.
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3.2. Bone Microstructure
While no statistically significant differences were found in the microstructure of adjacent bone
in the PLA and control group (p < 0.05), a tendency to better outcomes was observed in the former.
Specifically, BV/TV values in the control group tended to be lower than in the PLA group (Figure 11,
Table 2). In both groups, the values of the BV/TV tended to increase with the time elapsed since the
reconstruction. However, considerable variance in BV/TV values was observed, especially in the
controls, as shown by relatively high standard deviations.
Table 2. Microstructural parameters of tibial and femoral tunnels at 6 and 12 weeks post-ACL.
Variable
Tibia Femur
6 Weeks 12 Weeks p-Value 6 Weeks 12 Weeks p-Value
BV/TV
Controls 20.63 ± 8.04 24.98 ± 6.50 0.470487 19.73 ± 4.90 21.90 ± 4.22 0.470487
PLA group 22.30 ± 3.42 26.51 ± 4.81 0.103563 21.15 ± 4.36 23.22 ± 2.73 0.245279
p-value 0.671126 0.552215 0.932324 0.749119
Tb.Th
Controls 0.44 ± 0.16 0.50 ± 0.37 0.665006 0.37±0.10 0.34 ± 0.07 0.885234
PLA group 0.44 ± 0.09 0.45 ± 0.05 0.494837 0.34±0.04 0.35 ± 0.04 0.332922
p-value 0.798907 0.932324 0.671126 0.594033
Conn.D
Controls 1.61 ± 0.81 1.63 ± 0.14 0.885234 1.27 ± 0.44 1.72 ± 0.45 0.312322
PLA group 1.80 ± 0.46 1.57 ± 0.25 0.156255 1.95 ± 0.61 2.05 ± 0.16 0.948533
p-value 0.671126 0.932324 0.074532 0.240956
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While in the PLA group, Tb.Th values for the bone adjacent to the tibial and femoral tunnels were
essentially the same at 6 and 12 weeks post-reconstruction, higher variance in the trabecular thickness
at various study time points was observed in the control group (Table 2).
At 6 weeks after the reconstruction, Conn.D values for the tibial tunnel in the PLA group tended
to be higher than in the controls, whereas virtually no difference in Conn.D values for the tibial tunnel
in the PLA and control group was observed at 12 weeks. Regardless of the study timepoint, a trend
towards a between-group difference in Conn.D values for the femoral tunnel was observed in favor of
the PLA group (Table 2).
3.3. Three-Dimensional Visualization
The microstructure of bone remodeling is depicted in Figure 8. As shown in the figure, the edges of
the bone tunnel in the PLA group were smooth, and no evidence of a non-uniform tunnel enlargement
was observed. Also, the formation of the callus at both study timepoints seemed to be better in the PLA
group than in the controls (Figure 8a,b). Regardless of the study group, the remodeling process was
more advanced at 12 weeks post-reconstruction, which is consistent with the increase in BV/TV values.
4. Discussion
Early osteointegration of the tendon graft is crucial for successful rehabilitation and return to
normal activities of daily living. The aim of this study was to improve the quality of tendon-bone
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fusion after ACL reconstruction. However, rather than focusing on soft tissues, such as the tendon, or
mechanical properties of the tendon-stent-bone system, the study centered around interactions between
the stent and the bone, especially bone remodeling after implantation of the stent. In the earlier animal
study using a finite element analysis, we demonstrated that placement of the stent between the bone
and the graft had a beneficial effect on the stress-strain response (See: Appendix A). The PLA tube was
designated to act as a “shock absorber and stabilizer” during the ligament movements, preventing
hypermobility of the graft within the bone tunnel. The numerical analysis demonstrated that the
insertion of the stent contributed to a more favorable distribution of forces and lesser strain within the
bone tunnel and created uniform conditions at the whole tunnel length. Based on those findings, we
hypothesized that the implant not only acted as a scaffold for bone cells but might also protect the
graft during the implantation and prevent the undesirable tunneling phenomenon. The aim of our
present study was to verify this hypothesis in an animal model.
In our present study, we analyzed the influence of the PLA tube on bone tunnel remodeling using
high-resolution micro-CT imaging; this enabled us to determine a set of objective parameters, such as
tunnel diameter and volume, as well as histomorphometric characteristics of adjacent bone, such as
BV/TV, Tb.Th., and Conn.D. The three-dimensionally molded stent was used as a buffer to minimize or
eliminate undesired effects associated with post-traumatic or post-operative bone damage. Moreover,
the stent was intended to act as a “sealant” filling the space between the tendon graft and bone tunnel
wall, and hence, preventing penetration of synovial fluid into the tunnel. This would minimize the
unfavorable effects of proinflammatory cytokines contained in the synovial fluid on bone remodeling,
especially the BTE phenomenon.
We analyzed the diameters of the bone tunnels as a marker of potential BTE and a measure
of the PLA tube effect on bone healing. Our findings suggested that the use of the PLA implant
might not prevent the BTE completely, as the diameters of the femoral tunnel increased with the
time elapsed since the reconstruction procedure. However, it needs to be stressed that no significant
changes in the diameters of the tibial tunnel were observed over time in the PLA group. BTE might
be a consequence of too early load of the operated limb, as the study animals did not undergo any
controlled post-procedure rehabilitation, and the only factor limiting their activity was postoperative
pain. However, it should be stressed that according to some rehabilitation protocols, human patients
after ACL reconstruction are expected to weight-bear the operated extremity early after the procedure
and to walk without crutches or braces. Nevertheless, our study showed that implantation of the PLA
tube prevented the excessive widening of the bone tunnels.
Furthermore, a comparative analysis of femoral tunnel diameters in three segments (entry,
midportion, and exit) demonstrated that in the control group, the tunnel tended to be wider at its
entry. This might be a consequence of synovial fluid penetration to this segment of the tunnel and the
detrimental effect of proinflammatory cytokines contained in the fluid on bone remodeling. In turn,
the diameters of the three segments of the femoral tunnel in the PLA group were essentially the same,
implying that insertion of the PLA tube might prevent the excessive inflow of the synovial fluid and
minimize the harmful effects of proinflammatory cytokines.
To provide a better insight into the role of the PLA stent in bone remodeling after ACL
reconstruction, we also analyzed the microstructure of adjacent bone. While the PLA group and
the controls did not differ significantly in terms of their BV/TV values, the analysis of the latter in
conjunction with Conn.D suggested that the use of the PLA stent might promote the faster formation
of new bone. An increase in trabecular thickness and connectivity constitutes a response to mechanical
overload [52]. After insertion of the PLA tube into the bone tunnel, some mechanical loads might be
absorbed by the stent, rather than being directly delivered to the bone. Due to the resultant lesser
mechanical load, the trabecular thickness in the PLA group did not increase significantly over time
and was essentially the same at both 6 and 12 weeks post-reconstruction. This implied that the PLA
stent prevented a non-uniform distribution of forces within the bone tunnel, creating a more stable
environment for new bone formation. In contrast, variance in the trabecular thickness in the control
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group increased considerably with the time elapsed since the reconstruction procedure. The beneficial
effect of the PLA stent on the remodeling of the adjacent bone was also confirmed by a tendency
to higher connectivity density, especially around the femoral tunnel. Higher connectivity density
reflected a larger number of connections between the trabeculae in the PLA group. Furthermore, the
porosity of 45% and perforations of the stent could promote the accumulation of biological material
from the bone marrow blood in the form of incubation over the entire surface of the stent and support
bone tissue overgrowth.
Strengths and Limitations
Our present study has several strengths and limitations. We proposed a new, accurate method to
analyze bone remodeling after ACL reconstruction. Specifically, we resliced high-resolution micro-CT
images to obtain accurate measurements in axial cross-sections. The results of previous studies, in
which the images were not adjusted by reslicing [53,54], might have been biased due to a slight
axial displacement of the examined cross-sections. In our opinion, this could have a considerable
impact on the results, as the measurements of cross-sections that are not perfectly perpendicular might
be slightly inaccurate. To improve the reproducibility of the measurements, we applied automatic
thresholding (maximum entropy method); as a result, segmentation of the images was independent
of the observer, making the results more reliable. One potential limitation of this study might be
a too small number of examined sheep and a disproportion in the number of animals included in
the PLA and control group (16 and 8, respectively). However, even in such a small sample, we
found significant intergroup differences, confirming the beneficial effect of the PLA tube on bone
healing. Another potential limitation of this study might be a relatively short follow-up. According to
literature, full integration of the graft after ACL reconstruction takes longer than 12 weeks [55,56], and
an increase in bone tunnel diameter and BTE phenomenon might be observed even up to 12 months
post-reconstruction [57,58]. Nevertheless, the aim of our study was to analyze the changes that occurred
early after the reconstruction rather than the long-term outcomes of the procedure. Finally, interpreting
the hereby presented findings, one should remember that the sheep included in this study weight-bore
their operated limbs as soon as they recovered from anesthesia, whereas human patients after ACL
reconstruction are mobilized gradually and fully weight-bear their extremities even several weeks
after the procedure.
5. Conclusions
The results of this study suggested that the application of a bioresorbable PLA tube might facilitate
osteointegration of the tendon graft after the ACL reconstruction. The use of the bioresorbable PLA
stent might partially prevent BTE and stimulate new bone formation, as shown by changes in BV/TV
and Conn.D values. The beneficial effects of the PLA tube were likely associated with osteogenic and
osteoconductive properties of polylactide. Our findings implied that the PLA tube might positively
affect the quality of the graft-bone interface within the tibial and femoral tunnels, eventually resulting
in better osteointegration of the ACL graft.
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Appendix A
Appendix A.1 Construction of a Three-Dimensional Finite Element Model
The geometry of sheep femoral bone was modeled by the use of the advanced integrated CAx
system (CATIA v5). During the numerical experiment, the levels of stress and strain were calculated
for the two configurations: 1) cortical bone-cancellous bone stent-graft, and 2) cortical bone-cancellous
bone graft.
To perform numerical analysis, a model of sheep posterior femur was created and used to simulate
the postoperative load of the lower limb. The three-dimensional model, including both cortical
bone (approximately 2.4 mm thick) and cancellous bone, was designed with CATIA v5 software.
The model had a bone tunnel for graft implantation (with 4.5 mm in diameter, which corresponded to
the maximum outer diameter of the stent used in the proper experiment). The model was cut, so the
cortical bone was exposed, and the force corresponding to 1/4 of the sheep’s body weight was applied,
with a resultant load of 100 N. During the experiment, the model was fixed on its medial and lateral
condyle (Figure A1).
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Material properties of the blood, cortical, and cancellous bone tissue used during the numerical
study of fluid flow are summarized in Table A1. The calculations were carried out for the following
mechanical properties of polylactide (LATI Latigea B01 F1 Bio-Polymer): density = 1.26 g/cm3, tensile
strength = 55 MPa, modulus of elasticity = 3 GPa.
Table A1. Material properties of the blood, cortical, and cancellous bone.
Material Properties Blood Cortical Bone Cancellous Bone
Density (kg/cm3) 1060 - -
Proper heat (J/kg*K) 1006.43 - -
Thermal conductivity (W/m*K) 0.0242 - -
Viscosity (kg/m*s) 0.003 - -
Input speed (mm/s) 1 - -
Young’s modulus (MPA) - 17,000 300
Density (g/cm3) - 1.9 0.46
Poisson’s ratio - 0.3 0.3
Compressive strength (MPa) - 200 6
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Appendix A.2 Stress-Strain Analysis
The numerical simulation demonstrated that the stress was transmitted primarily through the
cortical layer of the bone, which is consistent with the real-life conditions (Figure A2). The levels of
stress in the graft and stent were small, no greater than several tens of Pa. Hence, to better visualize the
stress levels, the scale was changed, so the red color corresponded to >100 Pa tension. The stress-strain
analysis showed that implantation of the stent had a particular effect on stress distribution within the
cortical bone and stent/graft interface (Figure A3). The analysis demonstrated that the distribution
of the strain within the graft was more favorable after implantation of the stent (Figures A4 and A5).
This implied that implantation of the stent was not associated with additional stress for the graft.
Theoretically, a decrease in the strain at the bone/graft interface observed after implantation of the
stent should contribute to better ingrowth of the graft and reduce the likelihood of tunnel widening.
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